In the complex world of pharmaceutical manufacturing, the precise identification and control of chemical intermediates and impurities are paramount. One such compound that plays a significant role in ensuring drug quality is 5-(4-Chlorobutyl)-1-cyclohexyl-1H-tetrazole, identified by its CAS number 73963-42-5. This white solid, with the molecular formula C11H19ClN4, is particularly noted for its application as a key impurity in the synthesis of Cilostazol. Understanding its properties and sourcing it reliably is vital for pharmaceutical companies.

Cilostazol is a medication used to alleviate symptoms of intermittent claudication, acting as a phosphodiesterase III inhibitor that promotes vasodilation and inhibits platelet aggregation. The synthesis of such a complex molecule often involves multiple steps, and the presence of specific intermediates or by-products, like 5-(4-Chlorobutyl)-1-cyclohexyl-1H-tetrazole, must be carefully monitored. As a manufacturer and supplier in China, NINGBO INNO PHARMCHEM CO., LTD. recognizes the critical need for high-purity reference standards for these compounds. Ensuring the accurate quantification of impurities like 5-(4-Chlorobutyl)-1-cyclohexyl-1H-tetrazole is a cornerstone of good manufacturing practices (GMP) and essential for drug safety and regulatory compliance.

The chemical properties of 5-(4-Chlorobutyl)-1-cyclohexyl-1H-tetrazole, including its melting point and solubility, are well-documented, aiding researchers and quality control professionals in its handling and analysis. Its availability as a fine chemical intermediate means that laboratories focused on pharmaceutical research and development can readily obtain it for various analytical purposes. Whether for method development, validation, or routine quality checks, the consistent quality of this compound is a key factor. The ability to buy this intermediate from a trusted supplier like NINGBO INNO PHARMCHEM CO., LTD. ensures that researchers have access to the materials they need to maintain the highest standards in their work.

The demand for reliable pharmaceutical impurity standards underscores the importance of specialized chemical suppliers. Companies that focus on providing meticulously characterized intermediates and impurities, such as 5-(4-Chlorobutyl)-1-cyclohexyl-1H-tetrazole, are indispensable partners in the pharmaceutical ecosystem. NINGBO INNO PHARMCHEM CO., LTD. is committed to supporting these critical research efforts by offering this compound with guaranteed purity and a transparent supply chain. This dedication helps to streamline the drug development process, from early-stage research to commercial production, ultimately contributing to the delivery of safer and more effective medicines to patients worldwide.